Technical Analysis for VSTM - Verastem, Inc.

Grade Last Price % Change Price Change
D 10.62 -3.45% -0.38
VSTM closed down 3.45 percent on Monday, March 18, 2024, on 73 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
4 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down

Date Alert Name Type % Chg
180 Bearish Setup Bearish Swing Setup 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Bullish Engulfing Bullish -3.45%
Lower Bollinger Band Walk Weakness -3.45%
Multiple of Ten Bullish Other -3.45%
Outside Day Range Expansion -3.45%
Gapped Down Weakness -3.45%
Lower Bollinger Band Touch Weakness -3.45%
Oversold Stochastic Weakness -3.45%

   Recent Intraday Alerts

Alert Time
Down 5% about 7 hours ago
Lower Bollinger Band Support about 7 hours ago
Rose Above Previous Day's High about 12 hours ago
Down 3% about 12 hours ago
Down 2 % about 12 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Verastem, Inc., a biopharmaceutical company, focuses on discovering and developing proprietary small molecule drugs targeting cancer stem cells (CSCs) with companion diagnostics. Its programs target the Focal Adhesion Kinase (FAK) and the PI3K/mTOR signaling pathways. The company's lead FAK inhibitor, VS-6063, is in Phase I/Ib testing in ovarian cancer, as well as developing for the treatment of mesothelioma and breast cancer. It is also developing FAK inhibitor VS-4718 and PI3K/mTOR inhibitor VS-5584 in patients with advanced cancers. The company's product candidates target CSCs that have been implicated in aggressive cancers, metastasis, and chemotherapeutic resistance. Verastem, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Cancer Oncology Stem Cell Breast Cancer Ovarian Cancer Treatment Of Breast Cancer Signal Transduction mTOR Cancer Research Helio Companion Diagnostic Metastasis Advanced Cancer Mesothelioma Advanced Cancers Cancer Stem Cell Cancer Stem Cells Mtor Inhibitors

Is VSTM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 15.18
52 Week Low 4.2
Average Volume 144,521
200-Day Moving Average 9.38
50-Day Moving Average 11.72
20-Day Moving Average 12.03
10-Day Moving Average 11.36
Average True Range 0.79
RSI (14) 39.39
ADX 22.55
+DI 18.33
-DI 22.34
Chandelier Exit (Long, 3 ATRs) 11.46
Chandelier Exit (Short, 3 ATRs) 12.17
Upper Bollinger Bands 13.77
Lower Bollinger Band 10.29
Percent B (%b) 0.1
BandWidth 28.93
MACD Line -0.30
MACD Signal Line -0.03
MACD Histogram -0.2661
Fundamentals Value
Market Cap 268.35 Million
Num Shares 25.3 Million
EPS -3.89
Price-to-Earnings (P/E) Ratio -2.73
Price-to-Sales 51.84
Price-to-Book 4.01
PEG Ratio -1.89
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 11.57
Resistance 3 (R3) 11.63 11.38 11.41
Resistance 2 (R2) 11.38 11.14 11.35 11.35
Resistance 1 (R1) 11.00 10.99 10.88 10.94 11.30
Pivot Point 10.75 10.75 10.69 10.72 10.75
Support 1 (S1) 10.37 10.51 10.25 10.31 9.94
Support 2 (S2) 10.12 10.36 10.09 9.89
Support 3 (S3) 9.74 10.12 9.83
Support 4 (S4) 9.68